Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 2018

Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 2018

Wednesday October 24, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley Monk, MD, FACOG, FACS, Professor and Director of the Division of Gynecologic Oncology at Creighton University School of Medicine, discuss BRCA1+ ovarian patients, PARP inhibitors and the results of the SOLO-1 clinical trial

Featured Videos

Joyce O’Shaughnessy, MD, shares relevant findings from the MONARCH-2 trial

Véronique Diéras, MD, elaborates on the BROCADE 3 study presented at ESMO 2019

Dennis J. Slamon, MD, PhD, on the significance of the phase III MONALEESA-3 trial